METHOD OF DRUG TARGET VALIDATION

Details for Australian Patent Application No. 2002306684 (hide)

Owner RENOVIS, INC.

Inventors SERAFINI, Tito, Andrew

Pub. Number AU-A-2002306684

PCT Number PCT/US02/07294

PCT Pub. Number WO2002/072017

Priority 60/275,073 12.03.01 US

Filing date 12 March 2002

Wipo publication date 24 September 2002

Event Publications

19 December 2002 Complete Application Filed

  Priority application(s): 60/275,073 12.03.01 US

20 March 2003 Application Open to Public Inspection

  Published as AU-A-2002306684

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002306685-A NON-BLOCKING WAVELENGTH ROUTER ARCHITECTURE WITH WAVELENGTH REUSE CAPABILITY

2002306683-SELF-ALIGNED MRAM CONTACT AND METHOD OF FABRICATION